Anadys Pharmaceuticals, Inc. · San Diego, CA United States (NASDAQ: ANDS)
| 5871 Oberlin Dr., Ste. 200 | Phone: 858-530-3600 |
| San Diego, CA | Fax: 858-527-1540 |
| 92121 | |
| United States | 
Map This Company |
Anadys Pharmaceuticals, Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Anadys Pharmaceuticals has hepatitis and cancer in the crosshairs. The biotechnology company is developing new therapeutic treatments for those infected with hepatitis C (HCV) and other bacterial infections, as well as for applications in oncology. Anadys is exploring compounds that either act as direct antivirals or that stimulate the body's immune system responses to fight disease. In addition, Anadys Pharmaceuticals explores potential strategic alliances with other pharmaceutical firms for collaborative development or licensing arrangements. In late 2011, the company agreed to be acquired by
Anadys Pharmaceuticals, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: ANDS Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 27 |
Executives
15 executives listed for Anadys Pharmaceuticals, Inc.'s San Diego, CA location.
| Chairman | Stelios Papadopoulos | |
|---|---|---|
| President, CEO, and Director | Stephen Worland | |
| VP Finance and Operations, Principal Accounting Officer, and Principal Financial Officer | Peter Slover |